Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
Franklin
J P
JP
ARC Epidemiology Unit, Manchester University Medical School, UK. a.silman@manchester.ac.uk
Symmons
D P M
DP
Silman
A J
AJ
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008223:Lymphoma / Q000139:chemically induced*; D018570:Risk Assessment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha